# Trade Mark Journal No.2025/037 12 September 2025

## WO0000001871808 (5,10,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:23 May 2025
Date of designation in the UK: 23 May 2025

International priority date claimed: 26 November 2024 (European Union Intellectual Property Office (EUIPO)) (019111768)

Class 5
  Radiopharmaceutical products; diagnostic radiopharmaceutical preparations; radioactive pharmaceutical preparations for in vivo diagnostics; radioactive pharmaceutical preparations for therapeutic use; radioactive substances for medical purposes; radioactive elements for medical use; sealed radioactive substances for medical use; radio-isotope markers for therapeutic or diagnostic use; radioactive preparations for veterinary diagnosis; radiological contrast substances for medical purposes; contrasting agents for diagnostic ultrasound imaging; diagnostic reagents and contrast media for medical use; diagnostic agents for pharmaceutical use; none of the aforesaid being in relation to medicines containing iron, oral iron compositions for the treatment of iron deficiency and/or anaemia.
Class 10
  Radioisotope therapy apparatus and instruments; radiation oncology apparatus for medical use; radio cardiographic apparatus for medical purposes; apparatus for radionuclide imaging.
Class 42
  Research in the field of interventional radiology; research relating to radiopharmaceuticals, radiotherapeutics and radiodiagnostics; development of radiopharmaceutical preparations and medications and radiodiagnostics and radiotherapeutics.

Theranostik Pharma GmbH

Representative: VOSSIUS & PARTNER PATENTANWÄLTE RECHTSANWÄLTE MBB, Siebertstr. 3, 81675 München, GERMANY